Tesla to halt Shanghai factory production amid Covid curbs, Bloomberg News reports

Tesla to halt Shanghai factory production amid Covid curbs, Bloomberg News reports


Aerial view of the Tesla Shanghai Gigafactory on Mar. 29, 2021 in Shanghai, China.

Xiaolu Chu | Getty Images News | Getty Images

Tesla is planning to suspend production at its Shanghai factory for at least one day, Bloomberg News reported on Sunday, as China’s financial hub said it would go into a lockdown in two stages to conduct Covid-19 testing.

Tesla’s production in the plant will be halted on Monday, the report said, citing people familiar with the matter, adding that the electric carmaker hasn’t yet informed workers if it would extend the suspension beyond Monday.

Tesla did not immediately respond to Reuters’ request for comment.

Shanghai’s municipal government said on Sunday that all firms and factories will suspend manufacturing or work remotely during the lockdown.

Earlier this month, Tesla had to halt production at the factory for two days as China tightened its Covid-19 restrictions. The company then said it was trying its best to keep production going at the factory.



Source

Why India is in Trump’s crosshairs when crude is not even sanctioned
World

Why India is in Trump’s crosshairs when crude is not even sanctioned

Technicians stand next to an oil rig which is manufactured by Megha Engineering and Infrastructures Limited (MEIL) at an Oil and Natural Gas Corp (ONGC) plant, during a media tour of the plant in Dhamasna village in the western state of Gujarat, India, August 26, 2021.  Amit Dave | Reuters U.S. President Donald Trump added […]

Read More
Switzerland is in a uniquely difficult position when it comes to tariffs. Here’s why
World

Switzerland is in a uniquely difficult position when it comes to tariffs. Here’s why

Bern Skyline taken from the Rosengarten at sunrise in Switzerland. Church centre: Nydeggkirche Cathedral right: Berner Münster Bridge left: Nydeggbrücke Joe Daniel Price | Moment | Getty Images Switzerland is scrambling to make a trade deal with Washington as it looks to avoid a “triple blow” of economic problems after being hit with 39% tariffs […]

Read More
Novo Nordisk doubles down on Trump-friendly sales strategy
World

Novo Nordisk doubles down on Trump-friendly sales strategy

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Wegovy-maker Novo Nordisk said Wednesday that it was doubling down on direct-to-consumer sales as it contends with copycat compounders and Washington’s demands for lower domestic drug prices. Chief Financial Officer Karsten Munk Knudsen […]

Read More